APA
RCUS icon

American Portfolios Advisors’s Arcus Biosciences RCUS Stock Holding History

American Portfolios Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250
Closed -$2.52K – 2892
2019
Q4 		$2.52K Hold
250
– – ﹤0.01% 2511
2019
Q3 		$2.27K Hold
250
– – ﹤0.01% 2484
2019
Q2 		$1.99K Hold
250
– – ﹤0.01% 2483
2019
Q1 		$3.12K Hold
250
– – ﹤0.01% 2243
2018
Q4 		$2.69K Buy
+250
New +$2.92K ﹤0.01% 2060

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Portfolios Advisors's RCUS Position: Q1 2020 in Review

American Portfolios Advisors sold out of Arcus Biosciences (RCUS) in Q1 2020, closing a stake of 250 shares — an estimated $2.52K sold.

American Portfolios Advisors first reported a position in RCUS in Q4 2018 and held it in 5 quarters. The position peaked at $3.12K in Q1 2019. 92 funds tracked by Wall St. Rank hold RCUS as of Q1 2020.

  • American Portfolios Advisors reported no remaining Arcus Biosciences position as of Q1 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 250 Arcus Biosciences shares in Q1 2020, an estimated $2.52K.
  • American Portfolios Advisors first reported a position in Arcus Biosciences in Q4 2018 and held it in 5 quarters.
  • American Portfolios Advisors's Arcus Biosciences position peaked at $3.12K in Q1 2019.
  • 92 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2020.

Based on American Portfolios Advisors's 13F filing for Q1 2020, filed 24 Mar 2023.